POLICYBZRNSEPB Fintech LimitedMediumNeutral
Announced Thu, 7 Aug, 2025 · 21:21 IST

PB Fintech Limited has informed the Exchange about Transcript of Earnings Call

Analyst Day Multiyear TargetsMgmt Guided Margin ImprovementInvestor Communications View source PDFExplain this filing

POLICYBZR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.5%1-day move
₹1786.30
prior close
₹1771.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.3+0.2+0.3+4.5+2.2+3.7+2.8+4.7+7.0+2.0+0.7-1.1+0.8
Up moveDown movePending
AI summary

PB Fintech reported strong Q1 FY26 with total insurance premium of ₹6,616 Cr, up 36% year-on-year, led by Health insurance which grew 65%. Consolidated operating revenue rose 33% to ₹1,348 Cr, while consolidated PAT jumped from ₹19 Cr to ₹85 Cr, taking PAT margin from 2% to 6%. Renewal and trail revenue on a 12-month rolling basis hit ₹725 Cr, growing 43% YoY, providing a strong annuity-like base. The Credit business remained weak, with core credit revenue down 22% YoY. New initiatives (UAE, Corporate, POSP) grew ~50% YoY with adjusted EBITDA losses narrowing from -12% to -6%, and the UAE business turned profitable for the second straight quarter. Management reiterated that the near-term focus is on growth rather than profit optimization, with a 2030 target of ₹1 lakh Cr in insurance premium and a tax rate assumption of 8-10% for the next 18 months. Cost growth is guided at roughly two-thirds of revenue growth, signalling gradual operating leverage over time.

Likely market impact

The call reinforces a growth-first narrative: top-line momentum is robust, especially in Health and renewals, but management is deliberately deferring margin expansion to invest in scale and market share. For shareholders, this is a long-term compounding story—PAT has already inflected positively and the recurring revenue base is scaling fast, but near-term profit upgrades are unlikely. The reaffirmation of the 2030 ₹1 lakh Cr premium ambition and the multi-year cost-discipline commentary are supportive signals for long-term investors.